JP2017507189A5 - - Google Patents

Download PDF

Info

Publication number
JP2017507189A5
JP2017507189A5 JP2016573458A JP2016573458A JP2017507189A5 JP 2017507189 A5 JP2017507189 A5 JP 2017507189A5 JP 2016573458 A JP2016573458 A JP 2016573458A JP 2016573458 A JP2016573458 A JP 2016573458A JP 2017507189 A5 JP2017507189 A5 JP 2017507189A5
Authority
JP
Japan
Prior art keywords
methoxy
chloro
trifluoromethyl
compound
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016573458A
Other languages
English (en)
Japanese (ja)
Other versions
JP6303031B2 (ja
JP2017507189A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/021775 external-priority patent/WO2015134039A1/en
Publication of JP2017507189A publication Critical patent/JP2017507189A/ja
Publication of JP2017507189A5 publication Critical patent/JP2017507189A5/ja
Application granted granted Critical
Publication of JP6303031B2 publication Critical patent/JP6303031B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016573458A 2014-03-07 2014-03-07 Ii型糖尿病を処置するためのgpr120アゴニストとしてのイソチアゾール誘導体 Expired - Fee Related JP6303031B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/021775 WO2015134039A1 (en) 2014-03-07 2014-03-07 Isothiazole derivatives as gpr120 agonists for the treatment of type ii diabetes

Publications (3)

Publication Number Publication Date
JP2017507189A JP2017507189A (ja) 2017-03-16
JP2017507189A5 true JP2017507189A5 (https=) 2017-04-20
JP6303031B2 JP6303031B2 (ja) 2018-03-28

Family

ID=50391464

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016573458A Expired - Fee Related JP6303031B2 (ja) 2014-03-07 2014-03-07 Ii型糖尿病を処置するためのgpr120アゴニストとしてのイソチアゾール誘導体

Country Status (8)

Country Link
EP (2) EP3114123B1 (https=)
JP (1) JP6303031B2 (https=)
CN (1) CN106414434B (https=)
AU (1) AU2014385276B2 (https=)
CA (1) CA2941445A1 (https=)
ES (2) ES2887011T3 (https=)
MX (1) MX367852B (https=)
WO (1) WO2015134039A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2944572T3 (es) 2016-03-15 2023-06-22 Univ London Queen Mary Procedimiento de tratamiento de la obesidad
JP6809278B2 (ja) * 2017-02-17 2021-01-06 Jnc株式会社 重合性液晶化合物、重合性液晶組成物および液晶重合膜
JP2021517142A (ja) 2018-03-15 2021-07-15 アクザム ソシエタ ペル アチオニ 置換ピラゾールffa4/gpr120受容体作動薬
CN118040044B (zh) * 2023-11-07 2024-09-13 南昌大学 一种电解液与锂离子电池

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011255A1 (en) * 1997-08-28 1999-03-11 Ono Pharmaceutical Co., Ltd. Peroxisome proliferator-activated receptor controllers
JP4594611B2 (ja) * 2002-11-08 2010-12-08 武田薬品工業株式会社 受容体機能調節剤
GB0405033D0 (en) * 2004-03-05 2004-04-07 Karobio Ab Novel pharmaceutical compositions
NZ592603A (en) * 2008-10-21 2013-02-22 Metabolex Inc Aryl gpr120 receptor agonists and uses thereof
AR074760A1 (es) * 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
CN105209446A (zh) * 2013-03-14 2015-12-30 詹森药业有限公司 用于治疗ii型糖尿病的gpr120激动剂

Similar Documents

Publication Publication Date Title
JP2020502111A5 (https=)
RU2019121871A (ru) Новые производные фенилпропионовой кислоты и их применение
JP2016500661A5 (https=)
JP2017505293A5 (https=)
JP2009531292A5 (https=)
JP2011502958A5 (https=)
JP2017507189A5 (https=)
RU2010107169A (ru) Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого
JP2015537015A5 (https=)
CN112955448A (zh) 芳环或芳杂环类化合物及其制备方法和医药用途
JP2017511794A5 (https=)
JP2010519260A5 (https=)
CA2558585A1 (en) Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
JP2013532668A5 (https=)
JP2008521829A5 (https=)
JP2014507455A5 (https=)
JP2016535772A5 (https=)
JP2009530398A5 (https=)
CA2662305A1 (en) Heterocyclic gpr40 modulators
JP2015517579A5 (https=)
JP2014502979A5 (https=)
JP2016528273A5 (https=)
JP2010522710A5 (https=)
JP2015506993A5 (https=)
JPWO2022025242A5 (https=)